Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation

  • STATUS
    Recruiting
  • participants needed
    60
  • sponsor
    Medical University of Vienna
Send
Updated on 5 August 2020
See if I qualify
blood transfusion
deficiency
iron
liver transplant
anemia
packed red blood cells
orthotopic liver transplant
prbcs
transfusion of packed red blood cells

Summary

The aim of this study is to investigate whether therapy with intravenous iron carboxymaltose in patients with iron deficiency anemia (IDA) listed for orthotopic liver transplantation (OLT) increases hemoglobin concentrations and reduces intraoperative transfusion of packed red blood cells (PRBCs). The investigators hypothesize that therapy with intravenous iron will increase hemoglobin concentrations and reduce intraoperative transfusion of PRBCs in patients with IDA listed for OLT.

Details
Condition Hemorrhage, Hemorrhage, Liver transplant, Organ Transplantation
Age 18years - 100years
Treatment Placebo, Iron Carboxymaltose
Clinical Study IdentifierNCT04475887
SponsorMedical University of Vienna
Last Modified on5 August 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

patients listed for OLT with positive screening for IDA

Exclusion Criteria

Age <18 years
Hemochromatosis
Iron utilization disorders
Non-IDA
Therapy with erythropoietin-stimulating agents or intravenous iron within 4 weeks prior to screening
Previous allergic reactions against intravenous iron formulations
Transfusion within 2 weeks prior to screening
Complete portal vein thrombosis
High-urgency OLT
Pregnancy
Sepsis or severe infection
Immunosuppressive therapy
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

blood transfusion
deficiency
iron
liver transplant
anemia
packed red blood cells
orthotopic liver transplant
prbcs
transfusion of packed red blood cells

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.